Position history for MARSHALL WACE, LLP's holdings in CONNECT BIOPHARMA HLDGS LTD
MARSHALL WACE, LLP holds 66,013 shares of CNTB (CONNECT BIOPHARMA HLDGS LTD), worth $172,954 as of 2026-Q1. The position was decreased (-48.6% shares). CNTB represents 0.0% of MARSHALL WACE, LLP's portfolio.
Current Value
$172,954
Current Shares
66,013
Total Value Change
+$87,068
Total Shares Change
+7,982
Other major holders of CNTB: MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC
Decreased |
| 66,013 |
-48.6% |
| $172,954 |
| 0.0% |
| $2.48 |
0 |
| 2025-Q4 | Increased | 128,368 | +121.2% | $361,998 | 0.0% | $2.70 | 38 |
| 2025-Q3 | New | 58,031 | - | $85,886 | 0.0% | $1.32 | 30 |